In experimental arthritis, we have shown that the transfer of the main producers of IL-10, namely CD19+CD21hiCD23hiCD1dhi transitional 2 marginal zone precursor B cells (T2-MZP), prevents or ameliorates established disease [9,19]. The gene discussed is IL10; the disease is Arthritis.